Akari Therapeutics, Plc (AKTX) has a market capitalization of $4.14M and trades at $4.63. The 52-week range is 4.155-63.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-24.00.
The stock has a beta of 0.29, operates in the Healthcare sector.
